Evidence map›Paper›PMID 31816088›Full record

ArticleGigaScience2019

Accessible and reproducible mass spectrometry imaging data analysis in Galaxy.

Melanie Christine Föll, Lennart Moritz, Thomas Wollmann, Maren Nicole Stillger, Niklas Vockert, Martin Werner, Peter Bronsert, Karl Rohr, Björn Andreas Grüning, Oliver Schilling

Abstract read
In one paragraph

Article in GigaScience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Spatial pharmacology using mass spectrometry imaging.Trends in pharmacological sciences · 2024
    Review
  7. aXonica: A support package for MRI based Neuroimaging.Biotechnology notes (Amsterdam, Netherlands) · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Melanie Christine FöllInstitute of Surgical Pathology, Medical Center - University of Freiburg, Breisacher Straße 115a, 79106 Freiburg, Germany.
Lennart MoritzInstitute of Surgical Pathology, Medical Center - University of Freiburg, Breisacher Straße 115a, 79106 Freiburg, Germany.
Thomas WollmannBiomedical Computer Vision Group, BioQuant, IPMB, Heidelberg University, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany.
Maren Nicole StillgerInstitute of Surgical Pathology, Medical Center - University of Freiburg, Breisacher Straße 115a, 79106 Freiburg, Germany.
Niklas VockertBiomedical Computer Vision Group, BioQuant, IPMB, Heidelberg University, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany.
Martin WernerInstitute of Surgical Pathology, Medical Center - University of Freiburg, Breisacher Straße 115a, 79106 Freiburg, Germany.
Peter BronsertInstitute of Surgical Pathology, Medical Center - University of Freiburg, Breisacher Straße 115a, 79106 Freiburg, Germany.
Karl RohrBiomedical Computer Vision Group, BioQuant, IPMB, Heidelberg University, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany.
Björn Andreas GrüningDepartment of Computer Science, University of Freiburg, Georges-Köhler-Allee 106, 79110 Freiburg, Germany.
Oliver SchillingInstitute of Surgical Pathology, Medical Center - University of Freiburg, Breisacher Straße 115a, 79106 Freiburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMass spectrometry imaging is increasingly used in biological and translational research because it has the ability to determine the spatial distribution of hundreds of analytes in a sample. Being at the interface of proteomics/metabolomics and imaging, the acquired datasets are large and complex and often analyzed with proprietary software or in-house scripts, which hinders reproducibility. Open source software solutions that enable reproducible data analysis often require programming skills and are therefore not accessible to many mass spectrometry imaging (MSI) researchers.

findingsWe have integrated 18 dedicated mass spectrometry imaging tools into the Galaxy framework to allow accessible, reproducible, and transparent data analysis. Our tools are based on Cardinal, MALDIquant, and scikit-image and enable all major MSI analysis steps such as quality control, visualization, preprocessing, statistical analysis, and image co-registration. Furthermore, we created hands-on training material for use cases in proteomics and metabolomics. To demonstrate the utility of our tools, we re-analyzed a publicly available N-linked glycan imaging dataset. By providing the entire analysis history online, we highlight how the Galaxy framework fosters transparent and reproducible research.

conclusionThe Galaxy framework has emerged as a powerful analysis platform for the analysis of MSI data with ease of use and access, together with high levels of reproducibility and transparency.

Indexed as

Computational BiologyData AnalysisHumansMass SpectrometryMetabolomicsProteomicsReproducibility of ResultsSoftwareTranslational Research, Biomedicalcomputational workflowsGalaxyMALDI imagingmass spectrometry imagingmetabolomicsproteomicsreproducibilityspatially resolved mass spectrometry

Identifiers

PMID31816088
PMCPMC6901077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.